Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

35 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers.
Sturgeon CM, Duffy MJ, Stenman UH, Lilja H, Brünner N, Chan DW, Babaian R, Bast RC Jr, Dowell B, Esteva FJ, Haglund C, Harbeck N, Hayes DF, Holten-Andersen M, Klee GG, Lamerz R, Looijenga LH, Molina R, Nielsen HJ, Rittenhouse H, Semjonow A, Shih IeM, Sibley P, Sölétormos G, Stephan C, Sokoll L, Hoffman BR, Diamandis EP; National Academy of Clinical Biochemistry. Sturgeon CM, et al. Clin Chem. 2008 Dec;54(12):e11-79. doi: 10.1373/clinchem.2008.105601. Clin Chem. 2008. PMID: 19042984
Tumor markers: from laboratory to clinical utility.
Schrohl AS, Holten-Andersen M, Sweep F, Schmitt M, Harbeck N, Foekens J, Brünner N; European Organisation for Research and Treatment of Cancer (EORTC) Receptor and Biomarker Group. Schrohl AS, et al. Mol Cell Proteomics. 2003 Jun;2(6):378-87. doi: 10.1074/mcp.R300006-MCP200. Epub 2003 Jun 17. Mol Cell Proteomics. 2003. PMID: 12813140 Free article. Review. No abstract available.
Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer.
Schrohl AS, Christensen IJ, Pedersen AN, Jensen V, Mouridsen H, Murphy G, Foekens JA, Brunner N, Holten-Andersen MN. Schrohl AS, et al. Mol Cell Proteomics. 2003 Mar;2(3):164-72. doi: 10.1074/mcp.M300019-MCP200. Epub 2003 Apr 2. Mol Cell Proteomics. 2003. PMID: 12672830 Free article.
[An 11-month-year-old girl with repeated respiratory infections].
Holten-Andersen MN, Sulheim D, Indrebø M, Holmström H. Holten-Andersen MN, et al. Tidsskr Nor Laegeforen. 2010 Apr 22;130(8):846-8. doi: 10.4045/tidsskr.09.0632. Tidsskr Nor Laegeforen. 2010. PMID: 20418932 Free article. Norwegian.
35 results